These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 464729)

  • 1. [Clinical effect of a new 1-4-dihydropyridine derivative, YC-93, in patients with cerebrovascular diseases (author's transl)].
    Handa J; Koyama T; Tsuji H; Ishijima Y; Teraura T
    Nihon Geka Hokan; 1979 May; 48(3):400-3. PubMed ID: 464729
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical experience with a new coronary-active substance (BAY 1 1040).
    Kobayashi T; Ito Y; Tawara I
    Arzneimittelforschung; 1972 Feb; 22(2):380-9. PubMed ID: 5067492
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of Nifedipine on human coronary venous oxygen saturation at constant heart rates].
    Schwarzkopf HJ; Schaefer J; Schöttler M; Sedlmeyer I; Nordmann KJ
    Arzneimittelforschung; 1972 Feb; 22(2):367-70. PubMed ID: 5067489
    [No Abstract]   [Full Text] [Related]  

  • 4. Cerebrovascular effects of YC-93, a new vasodilator, in dogs, monkeys and human patients.
    Takenaka T; Handa J
    Int J Clin Pharmacol Biopharm; 1979 Jan; 17(1):1-11. PubMed ID: 33121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental cerebral vasospasm in cats: modification by a new synthetic vasodilator YC-93.
    Handa Y; Yoneda S; Koyama T; Matsuda M; Handa H
    Surg Neurol; 1975 Apr; 3(4):195-9. PubMed ID: 1145417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cerebral vascular effects of a new derivative of 1,4-dihydropyridine (YC-93), with special reference to its effect on the experimental basilar artery spasm in cats (author's transl)].
    Handa J
    Nihon Geka Hokan; 1975 Jul; 44(4):343-51. PubMed ID: 1238067
    [No Abstract]   [Full Text] [Related]  

  • 7. Vasodilator profile of a new 1,4-dihydropyridine derivative, 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)]-ethyl ester 5-methyl ester hydrochloride (YC-93).
    Takenaka T; Usuda S; Nomura T; Maeno H; Sado T
    Arzneimittelforschung; 1976; 26(12):2172-8. PubMed ID: 1037267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of the nitrophenyl-dimethyl-dihydropyridine derivative nifedipine on intercoronary collateral circulation.
    Kanazawa T; Suzuki N; Ino-oka E; Takahashi T; Mori A
    Arzneimittelforschung; 1974 Sep; 24(9):1267-74. PubMed ID: 4479789
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemodynamic and therapeutic effect of BAY a 1040 on the patients with ischemic heart disease.
    Hayase S; Hirakawa S; Hosokawa S; Mori N; Kanyama S
    Arzneimittelforschung; 1972 Feb; 22(2):370-3. PubMed ID: 4554632
    [No Abstract]   [Full Text] [Related]  

  • 10. The clinical effect of 4-(2'-nitrophenyl)-2,6-dimethyl-3,5-dicarbomethoxy-1,4-dihydropyridine (BAY a 1040) on angina pectoris evaluated by sequential analysis.
    Kimura E; Mabuchi G; Kikuchi H
    Arzneimittelforschung; 1972 Feb; 22(2):365-7. PubMed ID: 4623700
    [No Abstract]   [Full Text] [Related]  

  • 11. [The treatment of states of failure due to cerebral atrophy with beta-pyridyl-carbinol (Ronicol)].
    Oesterreich K; Tellenbach H
    Nervenarzt; 1967 Jan; 38(1):34-6. PubMed ID: 6047731
    [No Abstract]   [Full Text] [Related]  

  • 12. Clevidipine (Cleviprex) for IV treatment of severe hypertension.
    Med Lett Drugs Ther; 2008 Sep; 50(1295):73-4. PubMed ID: 18800023
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effects of cinepazide on cerebral circulation (author's transl)].
    Baba M; Kitamura K
    No To Shinkei; 1979 Jun; 31(6):621-9. PubMed ID: 465204
    [No Abstract]   [Full Text] [Related]  

  • 14. [A delayed-action therapeutic agent in chronic cerebral circulatory insufficiencies].
    Boudouresques J; Papy JJ; Daniel F
    Therapeutique; 1970 Oct; 46(8):789-92. PubMed ID: 5458910
    [No Abstract]   [Full Text] [Related]  

  • 15. [Rational selection of vasoactive drugs for the treatment of patients with vestibular dysfunction].
    Boĭko NV
    Vestn Otorinolaringol; 1991; (5):42-7. PubMed ID: 1755185
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experiences on the treatment of cerebral insufficiency and peripheral circulation disorders with the test preparation EP 50-100].
    Bock KJ
    Med Welt; 1972 Feb; 23(8):273-5. PubMed ID: 5012543
    [No Abstract]   [Full Text] [Related]  

  • 17. [Fenoxedil in cerebral and spinal cord circulatory insufficiency].
    Lehembre P; Warot P
    Lille Med; 1976 Jan; 21(1 suppl 1):1-3. PubMed ID: 1256224
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effectiveness of vasoactive preparations in patients with circulatory encephalopathy].
    Petelin LS; Shtok VN; Fedorova NV
    Klin Med (Mosk); 1988 Sep; 66(9):67-9. PubMed ID: 3204964
    [No Abstract]   [Full Text] [Related]  

  • 19. Nifedipine in angina pectoris. A multicentric clinical trial.
    Camerini F; Angelino PF; Bobba P; Caturelli G; Cherchi A; Giovannelli CA; Maggi GC
    G Ital Cardiol; 1974; 4(5):575-82. PubMed ID: 4215688
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of Nifedipine (BAY a 1040) on work electrocardiogram of angina pectoris patients].
    Loos A; Kaltenbach M
    Arzneimittelforschung; 1972 Feb; 22(2):358-62. PubMed ID: 5067488
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.